Cartesian Therapeutics, Inc. Restricted Cash and Investments, Noncurrent
Cartesian Therapeutics, Inc. (RNAC) had Restricted Cash and Investments, Noncurrent of $1.38 million as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndInvestmentsNoncurrent · last filed 2020-11-05
- 2020-09-30: Restricted Cash and Investments, Noncurrent $1.38M.
- 2020-06-30: Restricted Cash and Investments, Noncurrent $1.38M.
- 2020-03-31: Restricted Cash and Investments, Noncurrent $1.38M.
- 2019-12-31: Restricted Cash and Investments, Noncurrent $1.38M.
| Period end | Restricted Cash and Investments, Noncurrent | Restricted Cash and Investments, Noncurrent as first filed |
|---|---|---|
| 2020-09-30 | $1.38M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.38M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.38M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.38M 10-Q · filed 2020-11-05 | |
| 2019-09-30 | $1.38M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $279.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $2.65M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.46M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $2.70M 10-Q · filed 2018-05-09 | |
| 2018-01-01 | $329.00K 10-K · filed 2019-03-15 | $2.70M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $329.00K 10-K · filed 2019-03-15 | |
| 2017-09-30 | $316.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $316.00K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $316.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $316.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $316.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $316.00K 10-Q · filed 2016-08-09 | |
| 2015-12-31 | $316.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |